An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections.
ACS Cent Sci
; 8(8): 1145-1158, 2022 Aug 24.
Article
in En
| MEDLINE
| ID: mdl-36032774
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ACS Cent Sci
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: